Back to search

Peptide record

TPDB22308

Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Toxicity standard
14 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB22308
Antibacterial Anticancer Antifungal Antiparasitic Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia Antifp Antifungipept CAFPdb dbAMP HemoPI Hemolytic2 PD_Hemolysis
standard
No
A 14-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from Peptipedia, Antifp, Antifungipept, and other sources, with an available 3D structural model.
Sequence
KRLFKKLKFSLRKY
Physicochemical Analysis
C90H151N25O17
ANDCEQGHIMPTWV
K
1855.35
11.70
7
0
6
+7
1.82
-0.971
83.57
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
1490
80.31
2
Residue Composition
number
0
A
2
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
3
L
5
K
0
M
2
F
0
P
1
S
0
T
0
W
1
Y
0
V
Amino Acid Distribution
A: 0 R: 2 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 3 K: 5 M: 0 F: 2 P: 0 S: 1 T: 0 W: 0 Y: 1 V: 0
Chemical Descriptors
14
C90H151N25O17
1855.35
11.70
+7
1.82
-0.971
Evidence Records 5 records
Evidence 1 Activity

Activity

50% Hemolysis
Toxicity
51±21 µM
Hemolytic Cytotoxic
50% Hemolysis | 51±21 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides | FEBS Lett | 1999
Evidence 2 Activity

Activity

50% Hemolysis
Toxicity
83±13 µM
Hemolytic Cytotoxic
50% Hemolysis | 83±13 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides | FEBS Lett | 1999
Evidence 3 Activity

Activity

50% Hemolysis
Toxicity
35±3.0 µM
Hemolytic Cytotoxic
50% Hemolysis | 35±3.0 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides | FEBS Lett | 1999
Evidence 4 Activity

Activity

50% Hemolysis
Toxicity
20±2.5 µM
Hemolytic Cytotoxic
50% Hemolysis | 20±2.5 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
A critical comparison of the hemolytic and fungicidal activities of cationic antimicrobial peptides | FEBS Lett | 1999
Evidence 5 Hemolysis

Source & Reference

HemoPI PD_Hemolysis
PD_Hemolysis